Navigation Links
Weight-Loss Surgery Simplified
Date:6/2/2009

In clinical trial, patients recover faster from new procedure

TUESDAY, June 2 (HealthDay News) -- A new weight-loss procedure that involves sewing together the sides of the stomach holds promise as an alternative to traditional gastric bypass surgery, suggest preliminary findings from a clinical trial.

The incision-less procedure, called transoral gastric volume reduction (TGVR), prevents the stomach from relaxing to accept food. This reduces feelings of hunger and allows patients to feel full with less food, explained researchers at Brigham and Women's Hospital in Boston and the Cleveland Clinic Foundation.

Their ongoing clinical trial includes 18 patients with body mass index scores (BMIs) ranging from 30 to 45. A BMI of 30 or more is considered obese, according to the U.S. Centers for Disease Control and Prevention.

Nine months after undergoing TGVR, six patients had achieved a mean weight loss of 36.5 lbs. (an average of 34.4 percent of excess weight lost) and a reduction of waist circumference from 48 to 42.2 inches.

Six months after the procedure, the other 12 patients have achieved a mean loss of 27.9 lbs. (an average of 30.4 percent excess weight loss) and a reduction in waist circumference from 46.3 to 41.6 inches.

The findings were to be presented Monday at the Digestive Disease Week meeting in Chicago.

Compared to traditional weight-loss surgery, recovery from TGVR is much quicker, the researchers said.

"This procedure is safe and allows patients to resume their normal activities almost immediately," Dr. Christopher C. Thompson, director of developmental endoscopy at Brigham and Women's Hospital, said in a meeting news release. "It offers great potential for patients in lower BMI categories or for those who are not candidates for gastric bypass."

Patients must have a BMI of 40 or more to be eligible for standard gastric bypass surgery.

'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Weight-Loss Surgeries Extend Lives
2. UMass Medical School study identifies the best weight-loss plans for heart health
3. FTC Attacks Infomercial Marketer to Silence Best-Selling Authors Weight-Loss Tips
4. Psychiatric Woes Can Postpone Weight-Loss Surgery
5. Studies Examine Life After Weight-Loss Surgery
6. NutriSystem Advances Weight-Loss Category
7. New Weight-Loss Drug Shows Promise in Early Study
8. USA TODAY Weight-Loss Challenge Returns For 5th Year With Eight Weeks of Compelling Stories and Online Features
9. Some Weight-Loss Drugs Might Disrupt Brain Growth in Kids
10. Weight-Loss Aids Bought on Internet Might Harm Your Heart
11. Weight-Loss Surgery Weighed as Diabetes Rx
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weight-Loss Surgery Simplified
Weight-Loss Surgery Simplified
Breaking Medicine News(10 mins):Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 2Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 3Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 4Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 2Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 3Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 4Health News:Jefferson neurosurgeon helps draft new treatment guidelines for brain metastases 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 3Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 2Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 3Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 4
Other Medicine News:Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 2Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 4Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 5Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 2Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 3Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 4Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 2Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 3Health News:MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 3Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 4Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 5Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 6Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 7Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 2Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 3Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 4
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 1WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 2WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 3Diabetes drug linked to increased risk of heart failure 54955 1Diabetes drug linked to increased risk of heart failure 54955 2Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2
Other Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2